In CRC mice, it was shown that treatment with antibiotics and anti-PD-1 resulted in higher tumor volumes, indicating that a homeostatic gut microbiome is needed to achieve an optimal anti-PD-1 response (Xu et al., 2020). The gene discussed is PDCD1; the disease is neoplasm.